What Tracon Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% owner | Nov 10 | Open-market sale · S | −440,000 | $0.29 | −$129K | 0 |
| Opaleye Management Inc. | 10% owner | Nov 10 | Open-market sale · S | −4,324,008 | $0.29 | −$1.27M | 0 |
| Theuer Charles | PRESIDENT AND CEO | Oct 20 | Grant / award · A | +3,500 | $0.13 | +$467 | 406,417 |
| Theuer Charles | President and CEO | Apr 27 | Open-market buy · P | +47,000 | $0.75 | +$35.3K | 399,417 |
| Theuer Charles | President and CEO | Apr 26 | Open-market buy · P | +3,999 | $0.66 | +$2.64K | 352,417 |
| Theuer Charles | PRESIDENT AND CEO | Apr 20 | Grant / award · A | +3,500 | $0.14 | +$482 | 402,917 |
| Brown Scott B. | CHIEF FINANCIAL OFFICER | Apr 20 | Grant / award · A | +3,500 | $0.14 | +$482 | 25,128 |
| Opaleye Management Inc. | 10% owner | Mar 09 | Open-market buy · P | +174,508 | $1.38 | +$241K | 4,324,508 |
| Theuer Charles | President and CEO | Mar 01 | Open-market buy · P | +4,800 | $1.52 | +$7.3K | 344,918 |
| Theuer Charles | President and CEO | Feb 28 | Open-market buy · P | +200 | $1.52 | +$304 | 340,118 |
| Theuer Charles | President and CEO | Jan 18 | Open-market buy · P | +6,800 | $1.62 | +$11K | 339,918 |
| Brown Scott B. | Chief Financial Officer | Dec 29 | Open-market buy · P | +3,500 | $1.49 | +$5.22K | 21,628 |
| Larue William R | Director | Dec 21 | Open-market sale · S | −120 | $1.26 | −$151 | 7,763 |
| Theuer Charles | President and CEO | Dec 14 | Open-market buy · P | +23,000 | $1.29 | +$29.8K | 333,118 |
| Opaleye Management Inc. | 10% owner | Dec 14 | Open-market buy · P | +27,500 | $1.24 | +$34.1K | 440,000 |
| Opaleye Management Inc. | 10% owner | Dec 14 | Open-market buy · P | +140,000 | $1.26 | +$176K | 4,150,000 |
| Opaleye Management Inc. | 10% owner | Dec 06 | Open-market sale · S | −1,539 | $1.44 | −$2.22K | 4,010,000 |
| Opaleye Management Inc. | 10% owner | Dec 06 | In/At-money Exercise · X | +221,539 | $0.01 | +$2.22K | 4,011,539 |
| Theuer Charles | President and CEO | Nov 18 | Open-market buy · P | +13,900 | $1.41 | +$19.6K | 310,118 |
| Theuer Charles | President and CEO | Nov 03 | Open-market buy · P | +9,200 | $1.52 | +$14K | 296,218 |
Loading...
